Comparison Neoleukin Therapeutics (NGNE) with Competitors
Neoleukin Therapeutics (NGNE) industry is Biotechnology.
Free Cash Flow Yield
NGNE-13.51%
Industry-1.75%
Upside-11.76%
P/E
NGNE-6.03
Industry-20.52
Upside+1448.41%
P/S
NGNE583.60
Industry10.01
Upside+5728.11%
P/B
NGNE3.28
Industry5.15
Upside-36.19%